Exozymes Inc. (EXOZ) stock
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.43+0.12 (+3.63%)
Close on Nov 18, 2026Market cap $31.84MP/E –Yield –
Exozymes shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Exozymes's shares outstanding was 9M at Sep 30, 2026. For fiscal 2025 it was 8M, up 27.7% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8M | +27.7% |
| FY2024 | Dec 31, 2024 | 7M | +5.0% |
| FY2023 | Dec 31, 2023 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 9M | +10.8% |
| Q2 FY2026 | Jun 30, 2026 | 9M | +3.4% |
| Q1 FY2026 | Mar 31, 2026 | 8M | +1.1% |
| Q4 FY2025 | Dec 31, 2025 | 8M | +11.9% |
| Q3 FY2025 | Sep 30, 2025 | 8M | +34.1% |
| Q2 FY2025 | Jun 30, 2025 | 8M | +34.0% |
| Q1 FY2025 | Mar 31, 2025 | 8M | +33.9% |
| Q4 FY2024 | Dec 31, 2024 | 7M | +20.0% |
| Q3 FY2024 | Sep 30, 2024 | 6M | +0.0% |
| Q2 FY2024 | Jun 30, 2024 | 6M | – |
| Q1 FY2024 | Mar 31, 2024 | 6M | – |
| Q4 FY2023 | Dec 31, 2023 | 6M | – |
| Q3 FY2023 | Sep 30, 2023 | 6M | – |
See a number that looks wrong?